ArticleScientific reports2026
Integrated genomic and phenotypic characterization of antimicrobial resistance in Shiga toxin-producing Escherichia coli from asymptomatic carriers in Japan.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shiga toxin-producing Escherichia coli (STEC) carried by asymptomatic individuals constitute an important reservoir for community transmission, but large-scale analyses of antimicrobial resistance (AMR) in carrier-derived STEC remain limited. In this study, to obtain fundamental information relevant to the eradication of STEC carriage, we analyzed 495 STEC strains isolated from stool-screened asymptomatic carriers in Japan. All the isolates had been previously subjected to whole-genome sequencing and were classified into more than 100 serotypes, predominantly O156:H25 (13.5%), O174:H21 (7.7%), and O105:H7 (6.1%). Genome-based analysis revealed at least one antimicrobial resistance gene (ARG) in 83 isolates (16.8%), with aph(3″)-Ib, aph(6)-Id, sul2, tet(A), and blaTEM-1 being the most prevalent. Most carrier-derived STEC belonged to phylogroup B1, whereas ARGs were identified in isolates from diverse phylogenetic lineages. Comparative analysis revealed that the AMR profiles of carrier-derived STEC were similar to those of human commensal E. coli, whereas cattle commensal isolates exhibited a higher ARG prevalence. Phenotypic susceptibility testing revealed that resistance to ampicillin (n = 33) and tetracycline (n = 50) was the most common, whereas resistance to fluoroquinolones (n = 1) was infrequent and no resistance was observed to fosfomycin (n = 0) or amikacin (n = 0). Together, these findings provide a comprehensive overview of AMR in STEC from asymptomatic carriers in Japan and support the continued effectiveness of several antimicrobial agents while underscoring the importance of ongoing genomic surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.